Thymus vulgaris ct. linalool is characterised by linalool—a non-cyclic monoterpene alcohol—as its principal constituent, reaching concentrations of approximately 72-76% in southern French cultivars, with linalyl acetate as a significant secondary component.^[1] Unlike the thymol and carvacrol chemotypes, the absence of cytotoxic phenolic compounds renders this chemotype the least irritating of the T. vulgaris group, making it suitable for applications where dermal or mucosal tolerance is required.^[1] The linalool fraction demonstrates measurable anti-inflammatory activity in neuroglial models, reducing IL-6 and TNFa secretion in LPS-stimulated BV-2 microglia through NF-κB pathway suppression.^[2]